Bio-Works Technologies Secures Medicine Development Deal with US Biotech Company

MT Newswires · 2d ago
04:34 AM EDT, 08/25/2026 (MT Newswires) -- Bio-Works Technologies (BIOWKS.ST) was selected by a US biotechnology company as a development partner for a new medicine in a deal with a total order value of 2.8 million kronor. The Swedish biotechnology company said Tuesday the collaboration is currently in the development phase. The customer is a global biotechnology company developing medicines and vaccines using advanced mRNA technology.